OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
June 19, 2008
Also, Patheon to expand Puerto Rico facility, Creabilis Therapeutics appoints Tony Wilson CEO, more...
Effective July 1, 2008, the Office of Generic Drugs (OGD) will require abbreviated new drug applications (ANDAs) to include data that demonstrate the manufacturer's control of residual solvents.
June 12, 2008
In an assessment report about medicinal products containing heparin, the European Medicines Agency (EMEA)'s Committee for Medicinal Products for Human Use (CHMP) said it could not draw firm conclusions about the level of risk associated with unfractionated heparins (UFH) contaminated with oversulfated chondroitin sulfate (OSCS). Nevertheless, CHMP recommended that contaminated lots be withdrawn completely.
Also, Shire voluntarily recalls ADHD patch Daytrana
June 05, 2008
Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals, more...
June 02, 2008
The authors demonstrate that anecdotal reports of prednisone tablet variability are inaccurate.
The good, the bad, and the ugly about direct-to-consumer advertising.
An ambitious survey of characterization techniques presents current information.
May 29, 2008
Also, GVK BIO and Wyeth Pharmaceuticals form research agreement, Eli Lilly announces changes to management, more...
May 20, 2008
Cambridge Consultants is developing a low-cost portable instrument to test respiratory drug-delivery devices.
